2 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Chronic Hepaititis B: new trials by email Literature Review of Chronic Hepaititis B trials Research Report on Chronic Hepaititis B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB) ACT201 Injection, ACT201 Injection Placebo - Chronic Hepaititis B | Phase 1 | Recruiting | Xiamen Amoytop Biotech Co., Ltd. | 72 | 2026-08-06 | 2026-08-17 |
| A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B CRMA-1001 - Chronic Hepaititis B | Phase 1 / Phase 2 | Recruiting | nChroma Bio | 66 | 2025-12-22 | 2026-06-15 |
Hepatitis B, Chronic (1) · Hepatitis, Chronic (1)
Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Disease Attributes (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis B (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Virus Diseases (1)
Xiamen Amoytop Biotech Co., Ltd. (1) · nChroma Bio (1)
China (1) · France (1) · Hong Kong (1) · New Zealand (1) · United Kingdom (1)
Jing Zhang, Ph.D. (1) · Wenhong Zhang, Ph.D. (1)